WHAT IS RADIOFREQUENCY ABLATION
AND HOW DOES IT DESTROY TUMOURS?
Radiofrequency ablation uses a needle and electricity to generate precisely targeted heat that destroys cancer. No incision, no surgery, no radiation โ just a probe, a power source, and temperatures that cancer cells cannot survive.
analyticsAt a Glance
- check_circleNeedle electrode placed inside the tumour under CT or ultrasound guidance
- check_circleElectrical current generates heat to 60โ100ยฐC โ tumour cells destroyed by coagulative necrosis
- check_circleTumour plus 0.5โ1 cm safety margin destroyed; healthy tissue beyond that is unharmed
- check_circleEstablished for liver, kidney, lung, thyroid, and bone tumours โ 30+ years of clinical evidence
The RFA Mechanism: Electricity Becomes Heat Becomes Necrosis
RFA's mechanism is elegant in its simplicity. Understanding it removes the mystery of how a needle can permanently destroy a tumour.
โRFA is not a new idea โ surgeons have used electrical current to cut and coagulate tissue for over a century. RFA takes the same principle and applies it precisely inside a tumour, using imaging guidance to place the electrode exactly where it needs to be.โ
Step 1: Alternating Electrical Current
A radiofrequency generator (typically 375โ500 kHz) passes high-frequency alternating current through the electrode needle. This is the same electromagnetic frequency range as AM radio โ hence the name. The frequency is too high to cause muscle or nerve stimulation (which lower frequencies would cause), making the current safe to pass through living tissue.
Step 2: Resistive Heating in Tissue
As the alternating current flows from the electrode tip into the surrounding tissue and then to grounding pads on the patient's legs or back, the tissue resists the current flow. This resistance converts electrical energy to heat โ in the same way a wire heats up when current passes through it. Heat generation is concentrated around the electrode tip where current density is highest.
Step 3: Coagulative Necrosis at 60ยฐC+
Cell death begins at approximately 50ยฐC and is instantaneous and irreversible above 60ยฐC โ due to protein denaturation in cell membranes and enzymes. The target temperature at the tumour is 60โ100ยฐC. Temperatures above 100ยฐC cause charring and steam formation, which actually reduces electrical conductivity and limits further heat spread โ a self-limiting ceiling.
Step 4: The Ablation Zone
The region of tissue heated above 60ยฐC forms a zone of complete coagulative necrosis โ typically an ovoid or spherical volume 2โ5 cm in diameter per electrode position, depending on the RFA system and energy settings. The goal is a zone that covers the entire tumour plus at least a 0.5โ1 cm margin of adjacent tissue to ensure complete tumour destruction.
RFA Electrode Types: Monopolar, Bipolar, and Expandable Arrays
Different electrode designs achieve different ablation zone sizes and shapes. The interventional radiologist selects the electrode type based on tumour size and location.
Single Straight Electrode (Monopolar)
The simplest design โ a single insulated needle with an exposed active tip. Current flows from the electrode tip through the patient to grounding pads. Ablation zone is a sphere or ellipsoid around the tip. Single electrodes typically create ablation zones of 2โ3 cm per position. For tumours larger than 3 cm, the electrode is repositioned multiple times ("multiple overlapping ablations") or a multi-tined design is used.
Expandable Multi-Tined Electrodes
A retractable electrode that deploys multiple curved tines (hooks) from the needle shaft once positioned inside the tumour โ like an umbrella opening. Tines spread through the tumour over a 3โ5 cm diameter. The umbrella configuration increases ablation zone size in a single deployment, reducing the number of electrode positions needed for larger tumours. Examples: RITA/AngioDynamics starburst, Boston Scientific LeVeen systems.
Internally Cooled Electrodes
Chilled saline is circulated through the electrode shaft during energy delivery, cooling the electrode tip. This prevents charring at the electrode surface (which would reduce conductivity), allowing higher power delivery and larger ablation zones โ typically 3โ4 cm per position. Internally cooled single or cluster electrodes are the current standard in most centres. Examples: Medtronic (formerly Covidien) Cool-tip system.
Bipolar Electrodes
Current flows between two electrodes placed within the tumour rather than through the patient to grounding pads. This localises energy delivery more precisely and eliminates the risk of current concentration at grounding pad sites. Bipolar RFA is less common than monopolar but offers advantages in selected locations. Some newer systems use multipolar approaches with 3+ electrodes simultaneously.
RFA vs Other Thermal Ablation Techniques
How RFA compares to microwave ablation (MWA), cryoablation, and irreversible electroporation (IRE) โ all interventional oncology tools with distinct strengths.
| Feature | RFA | Microwave Ablation (MWA) | Cryoablation | IRE (NanoKnife) |
|---|---|---|---|---|
| Mechanism | Resistive heating (60โ100ยฐC) | Electromagnetic heating (60โ150ยฐC) | Freeze-thaw cycles (โ40ยฐC) | Electrical pulse membrane disruption |
| Heat Sink Sensitivity | High โ vessels dissipate heat | Lower โ overcomes heat sink better | Similar to RFA | Not affected by heat sink |
| Ablation Zone per Application | 2โ4 cm typically | 3โ7 cm possible; faster larger zones | 3โ5 cm; iceball visible on imaging | 3โ5 cm; no thermal margin |
| Speed | 10โ25 min per position | 5โ15 min per position; faster overall | 20โ40 min cycle | 5โ10 min |
| Near-Vessel Safety | Greater heat sink risk; vessel injury possible | Better perivascular performance than RFA | Safest near vessels โ ice cracks vessel wall | Safe near vessels โ non-thermal |
| Best Current Indications | Liver (HCC, CRC mets), kidney, lung, thyroid, bone | Liver (especially >3 cm HCC), lung, kidney | Kidney (good nephron-sparing), lung, bone pain | Perivascular liver/pancreas tumours |
| Evidence Base | Most extensive โ 30+ years | Growing rapidly; now rivals RFA for liver | Good for kidney; moderate for liver | Phase II/III; niche use |
| Cost | Lower โ most widely available | Moderate | Moderate โ cryo gases add cost | Highest โ specialised equipment |
Imaging Guidance: How the Needle Gets Into the Tumour
Precise electrode placement is everything in RFA. The margin of success or failure is measured in millimetres. Three imaging modalities guide electrode placement.
CT Guidance
The standard for most liver, lung, and kidney RFA. The patient lies in the CT scanner; intermittent CT acquisitions track the needle as it advances through skin and tissue toward the tumour. CT provides excellent anatomical detail in three planes, allows precise depth measurement, and confirms final electrode position. CT-fluoroscopy enables real-time needle guidance in experienced hands.
Ultrasound Guidance
Used for superficial liver tumours and kidney tumours clearly visible on ultrasound. Allows real-time needle visualisation during placement and during energy delivery โ the treating radiologist can monitor the ablation zone as it develops (appearing as an echogenic bubble on ultrasound). Faster and involves no radiation. Less useful for tumours poorly visualised on ultrasound or deep liver locations.
MRI Guidance
Less common but offers superior soft tissue contrast and the ability to thermally map the ablation zone in real time using MR thermometry. Specialised MR-compatible RFA systems are required. Used for selected cases where CT or ultrasound is inadequate โ particularly prostate RFA and selected liver cases.
The Heat Sink Effect: RFA's Most Important Limitation
The heat sink effect is the single most important factor limiting RFA success โ and the primary reason microwave ablation was developed as an improvement over RFA.
What the Heat Sink Effect Is
Blood flowing through vessels adjacent to a tumour carries heat away from the ablation zone โ just as a heat sink in electronics dissipates heat. The continuous flow of blood at 37ยฐC in a major vessel (hepatic vein, portal vein branch, renal vein) adjacent to the tumour keeps the near-vessel tissue cooler than the target temperature, preventing complete tumour destruction in that area.
Clinical Consequences
Perivascular tumours โ those within 0.5โ1 cm of a major vessel โ have significantly higher incomplete ablation and local recurrence rates with RFA than tumours located away from vessels. A tumour touching a hepatic vein may achieve complete ablation in 60โ70% of cases vs 90%+ for tumours distant from vessels. This is the primary reason microwave ablation (which generates much higher temperatures that overcome heat sink) is preferred for perivascular liver tumours.
Explore the RFA Knowledge Base
Learn more about specific RFA indications and evidence.
- RFA for Liver Cancer (HCC): Eligibility and Outcomes
- RFA vs Surgery for Small HCC: Randomised Trial Evidence
- TACE + RFA Combination for Intermediate HCC: The Chinese Standard
- RFA for Colorectal Liver Metastases: The CLOCC Trial
- What Is Microwave Ablation? A Patient Introduction
- Radiofrequency Ablation โ Full Treatment Page
Frequently Asked Questions
Common questions about what RFA is and how it works.
About the Procedure
Is RFA painful?
RFA is performed under conscious sedation (for most liver and kidney procedures) or general anaesthesia, so patients feel nothing during the procedure. Post-procedure discomfort โ post-ablation syndrome โ is common for 3โ7 days: flu-like symptoms with low-grade fever, mild pain or discomfort at the ablation site, and fatigue from tumour necrosis. This is managed with paracetamol and NSAIDs and is generally mild. Lung RFA can cause pleuritic chest pain and temporary pneumothorax risk that requires post-procedure monitoring.
How long does an RFA procedure take?
The actual ablation takes 10โ25 minutes per electrode position. For a single small tumour (<3 cm), the full procedure including anaesthesia, imaging setup, electrode placement, ablation, and recovery takes 2โ4 hours total. Multiple tumours or larger tumours requiring repositioning extend the procedure time. Most patients go home the same day or after one overnight stay.
Is RFA the same as microwave ablation?
No. Both are thermal ablation techniques that destroy tumours with heat, but they work differently. RFA uses electrical current to generate heat in tissue through resistive heating. Microwave ablation uses electromagnetic microwave energy to vibrate water molecules and generate heat โ reaching higher temperatures faster and being less affected by the heat sink effect of nearby blood vessels. For most indications the two achieve similar outcomes; microwave ablation is increasingly preferred for larger tumours and perivascular locations.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Is RFA the Right Treatment for Your Tumour?
Upload your imaging and medical reports. Our interventional oncology team will assess whether RFA is appropriate for your specific tumour size, location, and clinical situation.
For informational purposes only. RFA suitability requires evaluation by qualified interventional oncology specialists.